FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313237614> ?p ?o ?g. }

• W4313237614 endingPage "320" @default.
• W4313237614 startingPage "308" @default.
• W4313237614 abstract "Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disorder. Obesity is associated with increased prevalence and severity of AD for reasons that remain poorly understood. Myricetin, a dietary flavonoid found in fruits and vegetables, is known to have anti-inflammatory effects, but its role in AD is unclear. Thus, we investigated the effects of obesity on exacerbation AD lesions and evaluated the effects of myricetin on obese AD. Mice were fed normal diet (ND) or high-fat diet, and then 2,4-dinitrofluorobenzene was used to induce AD-like lesions. We found that obesity exacerbated AD lesions, and myricetin topical administration ameliorated symptoms and skin lesions of obsess AD mice, such as dermatitis scores, scratching behavior, epidermal thickness, and mast cell infiltration. In addition, myricetin reduced the levels of immunoglobulin E and histamine, inhibited the infiltration of CD4+T cells, and modulated the expression of Th1, Th2, Th17, and Th22 cytokines and pro-inflammatory factors (CCL17, CCL22, IL-1β, and TGF-β). Moreover, myricetin restored impaired barrier function by reducing transepidermal water loss, increasing lamellar body secretion, as well as upregulating the mRNA and protein expression of filaggrin. Western blot results showed that significantly increased levels of phosphorylated IκB and NF-κB p65 was observed in the obese AD mice compared with the AD mice fed ND, whereas the myricetin could downregulated the phosphorylations of IκB and NF-κB, and inhibited mRNA expression of iNOS and COX2. Taken together, our results suggest that myricetin treatment exhibits potentially protective effects against the obeseassociated AD by inhibiting inflammatory response and restoring skin barrier function." @default.
• W4313237614 created "2023-01-06" @default.
• W4313237614 creator A5050986123 @default.
• W4313237614 creator A5069071892 @default.
• W4313237614 creator A5069939735 @default.
• W4313237614 creator A5074091537 @default.
• W4313237614 creator A5081160539 @default.
• W4313237614 creator A5088961129 @default.
• W4313237614 date "2022-12-28" @default.
• W4313237614 modified "2023-10-02" @default.
• W4313237614 title "Myricetin treatment has ameliorative effects in DNFB-induced atopic dermatitis mice under high-fat conditions" @default.
• W4313237614 cites W1519686144 @default.
• W4313237614 cites W1542185599 @default.
• W4313237614 cites W1579116003 @default.
• W4313237614 cites W1741797126 @default.
• W4313237614 cites W1910647355 @default.
• W4313237614 cites W1927710737 @default.
• W4313237614 cites W1969869116 @default.
• W4313237614 cites W1988990442 @default.
• W4313237614 cites W1997103341 @default.
• W4313237614 cites W2001009396 @default.
• W4313237614 cites W2002600662 @default.
• W4313237614 cites W2003442566 @default.
• W4313237614 cites W2010855247 @default.
• W4313237614 cites W2014434238 @default.
• W4313237614 cites W2020186773 @default.
• W4313237614 cites W2028075093 @default.
• W4313237614 cites W2034775565 @default.
• W4313237614 cites W2044940018 @default.
• W4313237614 cites W2050366993 @default.
• W4313237614 cites W2055905930 @default.
• W4313237614 cites W2056207075 @default.
• W4313237614 cites W2059757891 @default.
• W4313237614 cites W2067510223 @default.
• W4313237614 cites W2083246404 @default.
• W4313237614 cites W2092204583 @default.
• W4313237614 cites W2097288778 @default.
• W4313237614 cites W2100784798 @default.
• W4313237614 cites W2109506046 @default.
• W4313237614 cites W2113158698 @default.
• W4313237614 cites W2118630839 @default.
• W4313237614 cites W2126007695 @default.
• W4313237614 cites W2134211542 @default.
• W4313237614 cites W2141249615 @default.
• W4313237614 cites W2147089380 @default.
• W4313237614 cites W2155066537 @default.
• W4313237614 cites W2166781237 @default.
• W4313237614 cites W2276769404 @default.
• W4313237614 cites W2464484300 @default.
• W4313237614 cites W2568590455 @default.
• W4313237614 cites W2610172333 @default.
• W4313237614 cites W2621708002 @default.
• W4313237614 cites W2769855353 @default.
• W4313237614 cites W2793752870 @default.
• W4313237614 cites W2807654228 @default.
• W4313237614 cites W2807735644 @default.
• W4313237614 cites W2885267330 @default.
• W4313237614 cites W2903437521 @default.
• W4313237614 cites W2924145723 @default.
• W4313237614 cites W2948053235 @default.
• W4313237614 cites W2978850149 @default.
• W4313237614 cites W3105788558 @default.
• W4313237614 cites W4211026773 @default.
• W4313237614 cites W4355500 @default.
• W4313237614 doi "https://doi.org/10.1093/toxsci/kfac138" @default.
• W4313237614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36575998" @default.
• W4313237614 hasPublicationYear "2022" @default.
• W4313237614 type Work @default.
• W4313237614 citedByCount "1" @default.
• W4313237614 countsByYear W43132376142023 @default.
• W4313237614 crossrefType "journal-article" @default.
• W4313237614 hasAuthorship W4313237614A5050986123 @default.
• W4313237614 hasAuthorship W4313237614A5069071892 @default.
• W4313237614 hasAuthorship W4313237614A5069939735 @default.
• W4313237614 hasAuthorship W4313237614A5074091537 @default.
• W4313237614 hasAuthorship W4313237614A5081160539 @default.
• W4313237614 hasAuthorship W4313237614A5088961129 @default.
• W4313237614 hasConcept C104317684 @default.
• W4313237614 hasConcept C126322002 @default.
• W4313237614 hasConcept C134018914 @default.
• W4313237614 hasConcept C142724271 @default.
• W4313237614 hasConcept C164027704 @default.
• W4313237614 hasConcept C185592680 @default.
• W4313237614 hasConcept C203014093 @default.
• W4313237614 hasConcept C2776415932 @default.
• W4313237614 hasConcept C2776914184 @default.
• W4313237614 hasConcept C2777810353 @default.
• W4313237614 hasConcept C2778004101 @default.
• W4313237614 hasConcept C2778173338 @default.
• W4313237614 hasConcept C2778329239 @default.
• W4313237614 hasConcept C2778370115 @default.
• W4313237614 hasConcept C2781263971 @default.
• W4313237614 hasConcept C55493867 @default.
• W4313237614 hasConcept C71924100 @default.
• W4313237614 hasConcept C95150158 @default.
• W4313237614 hasConcept C98274493 @default.
• W4313237614 hasConceptScore W4313237614C104317684 @default.
• W4313237614 hasConceptScore W4313237614C126322002 @default.

• next